Combinations and comparisons (Q41603266)

4 October 2017

1 reference

title

Combinations and comparisons (English)

1 reference

4 October 2017

van de Kerkhof PC

1

1 reference

4 October 2017

1 September 1997

1 reference

4 October 2017

Clinics in Dermatology

1 reference

4 October 2017

15

1 reference

4 October 2017

5

1 reference

4 October 2017

831-834

1 reference

Assessment of disease progress in psoriasis

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Measurement of involved surface area in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

On the limitations of the psoriasis area and severity index (PASI)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

The external treatment of psoriasis. A controlled investigation of the effects of coal tar

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

UV-B phototherapy of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Clinical aspects of photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

The approach to psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Effect of etretinate on cyclosporin metabolism in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900010-2

7 January 2021

10.1016/S0738-081X(97)00010-2

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9313980